Development of Chimeric Antigen Receptors Targeting T-cell Malignancies Using Two Structurally Different Anti-Cd5 Antigen Binding Domains in NK and CRISPR-edited T Cell Lines.
Oncoimmunology（2017）
关键词
anti-cds scFv,chimeric antigen receptor,immunotheraphy,lamprey variable lymphocyte receptor,T-cell lenkemia
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要